Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will Amylin Be Acquired? What The Wags Say…
Pharmalot
Thursday, March 29, 2012 - 10:18am
tags:
M&A, Bristol-Myers Squibb, Eli Lilly, AstraZeneca
Astellas extends deal to sell Pfizer's Lipitor in Japan
Reuters
Thursday, March 29, 2012 - 10:02am
tags:
Pfizer, Lipitor, statins, Japan, Astellas
Eli Lilly says psoriasis drug meets goal in study
Yahoo/AP
Thursday, March 29, 2012 - 10:01am
tags:
psoriasis, Eli Lilly, ixekizumab
Horizon Pharma sues Par Pharma over arthritis drug patent
Reuters
Thursday, March 29, 2012 - 9:57am
tags:
Par Pharmaceutical, Horizon Pharma, patents, Duexis, arthritis
FDA adds warnings to Forest Labs' Celexa label
Reuters
Wednesday, March 28, 2012 - 4:19pm
tags:
warnings, FDA, Forest Labs, Celexa, antidepressants
Mixed Data on Merck's Vorapaxar
Yahoo/Zacks.com
Wednesday, March 28, 2012 - 4:14pm
tags:
Merck, Vorapaxar, TRA-2P
Here's Where Abbott Laboratories Is Finding Its Growth
Motley Fool
Wednesday, March 28, 2012 - 4:05pm
tags:
Abbott Laboratories
Bristol-Myers in partnership for Alzheimer's test
Yahoo/AP
Wednesday, March 28, 2012 - 4:04pm
tags:
Alzheimer's disease, Bristol-Myers Squibb, Meso Scale Discovery
FDA OKs New Anemia Med That Challenges Amgen
Pharmalot
Wednesday, March 28, 2012 - 11:27am
tags:
FDA, Amgen, anemia, Epogen, Omontys, Affymax, Aranesp
Future Trends In RNAi Drug Delivery
Seeking Alpha
Wednesday, March 28, 2012 - 11:20am
tags:
RNAi, Alnylam
Is a Pfizer Breakup in the Cards? How Much Would it be Worth?
Barron's
Wednesday, March 28, 2012 - 11:06am
tags:
Pfizer
Allergan Botox works in overactive bladder studies
Reuters
Wednesday, March 28, 2012 - 11:06am
tags:
Botox, Allergan, overactive bladder
Amilyn Soars on News of Spurned Bristol-Myers Bid
Barron's
Wednesday, March 28, 2012 - 10:27am
tags:
Amylin, Bristol-Myers Squibb, M&A
Neurocrine's News Not As Bad As The Market Thinks
Seeking Alpha
Wednesday, March 28, 2012 - 10:20am
tags:
Neurocrine, Abbott Laboratories, NBI-98854, tardive dyskinesia
Large Market Opportunity Emerges For Oculus Technology
Seeking Alpha
Wednesday, March 28, 2012 - 10:19am
tags:
Oculus, GSK, JNJ, Novartis, Sanofi, Vivus
Pharma's 4 Biggest Losers
Seeking Alpha
Wednesday, March 28, 2012 - 10:17am
tags:
Abbott Laboratories, Watson, Mark, 3SBio
Cardiome Pharma 4Q loss shrinks on lower costs
Yahoo/AP
Wednesday, March 28, 2012 - 10:15am
tags:
Cardiome, earnings
Merck says key Vytorin study cleared to continue
Reuters
Wednesday, March 28, 2012 - 10:12am
tags:
Merck, Vytorin
Bristol-Myers offers $3.5 billion for Amylin-Bloomberg
Reuters
Wednesday, March 28, 2012 - 10:12am
tags:
Amylin, Bristol-Myers Squibb, M&A
Biogen executive team rakes in millions from its 2011 successes
Fierce Biotech
Tuesday, March 27, 2012 - 10:40am
tags:
Biogen Idec, George Scangos

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.